All eyes on a hurdle race for a SARS-CoV-2 vaccine

Nature. 2020 Oct;586(7830):501-502. doi: 10.1038/d41586-020-02926-w.
No abstract available

Keywords: Immunology; Medical research; SARS-CoV-2; Vaccines.

Publication types

  • News

MeSH terms

  • Adolescent
  • Adult
  • B-Lymphocytes / immunology
  • Betacoronavirus / immunology
  • COVID-19
  • COVID-19 Vaccines
  • Clinical Trials as Topic*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / prevention & control
  • Humans
  • Middle Aged
  • Pandemics / prevention & control
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / prevention & control
  • SARS-CoV-2
  • T-Lymphocytes / immunology
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence
  • Vaccination
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / adverse effects
  • Viral Vaccines / immunology*
  • Young Adult

Substances

  • COVID-19 Vaccines
  • Viral Vaccines